About the Authors
- Alienke J. Monsuur
-
Current address: Dutch Vaccine Institute, Bilthoven, The Netherlands
Affiliation Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands
- Paul I. W. de Bakker
-
Affiliations Broad Institute of Harvard and Massachusetts Institute of Technology (MIT), Cambridge, United States of America, Division of Genetics, Brigham and Women's Hospital, Harvard-Partners Center for Genetics and Genomics, Boston, United States of America
- Alexandra Zhernakova
-
Affiliation Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands
- Dalila Pinto
-
Affiliation Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands
- Willem Verduijn
-
Affiliation Section for Immunogenetics and Transplantation Immunology of the Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center (LUMC), Leiden, The Netherlands
- Jihane Romanos
-
Affiliation Genetics Department, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands
- Renata Auricchio
-
Affiliation Department of Pediatrics and European Laboratory for the Investigation of Food-Induced Diseases, University Federico II Naples, Napels, Italy
- Ana Lopez
-
Affiliation Pediatric Gastroenterology Unit, Fundación Investigación Hospital La Fe, Valencia, Spain
- David A. van Heel
-
Affiliation Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, United Kingdom
- J. Bart A Crusius
-
Affiliation Department of Pathology, Vrije Universiteit (VU) University Medical Centre, Amsterdam, The Netherlands
- Cisca Wijmenga
-
* E-mail: c.wijmenga@umcutrecht.nl
Affiliations Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands, Genetics Department, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands
Competing Interests
The HLA-DQ haplotyping was invented at the University Medical Centre Utrecht (UMC Utrecht) and will be developed and marketed by Genome Diagnostics BV. The UMC Utrecht may receive royalties from the worldwide sale of the technology. UMC Utrecht may distribute part of the royalty revenues to the inventors (CW and AM). None of the authors report a financial or other link with Genome Diagnostics BV. Genome Diagnostics had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.
Author Contributions
Conceived and designed the experiments: CW. Performed the experiments: AM AZ DP JR. Analyzed the data: AM AZ. Contributed reagents/materials/analysis tools: Pd WV Dv BC RA AL. Wrote the paper: Pd CW AM AZ.